Zosano Pharma Corporation

Quick facts

Phase 3 pipeline

• M207 Microneedle System
  M207 is a microneedle patch system designed to deliver drugs transdermally by piercing the skin barrier with microscopic needles.

Phase 2 pipeline

• C213 Microneedle System
• ZP-Zolmitriptan

Phase 1 pipeline

• A: M207 3.8mg, 30 min, upper arm
• B: M207 3.8 mg, 30 min, thigh
• C: M207 3.8 mg, 1 hr, upper arm
• D:zolmitriptan nasal spray
• ZP-PTH

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Zosano Pharma Corporation portfolio CI brief
• Zosano Pharma Corporation pipeline updates RSS